"Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma"

If you are interested in learning more about this trial, ResearchMatch can help by contacting the trial team for you. If you’re not a volunteer yet, you’ll first need to join ResearchMatch before we can share your contact information with the research team.